PubMed=3434911; DOI=10.2460/ajvr.1987.48.11.1642
Lauren G. Wolfe, Julian Linwood Oliver 3rd, Bonnie Buxton Smith, Maria A. Toivio-Kinnucan, Robert D. Powers, William R. Brawner, Ralph A. Henderson, Gerald H. Hankes;
Biologic characterization of canine melanoma cell lines.
Am. J. Vet. Res. 48:1642-1648(1987)

PubMed=15965647; DOI=10.1007/s00262-005-0025-6; PMCID=PMC11031070
Andrew N. Alexander, Michael K. Huelsmeyer, Ann Mitzey, Richard R. Dubielzig, Ilene D. Kurzman, E. Gregory MacEwen, David M. Vail;
Development of an allogeneic whole-cell tumor vaccine expressing xenogeneic gp100 and its implementation in a phase II clinical trial in canine patients with malignant melanoma.
Cancer Immunol. Immunother. 55:433-442(2006)

PubMed=22901430; DOI=10.1016/j.jcpa.2012.07.001; PMCID=PMC3535688
Esther Chon, Victoria Thompson, Simone Schmid, Timothy J. Stein;
Activation of the canonical Wnt/beta-catenin signalling pathway is rare in canine malignant melanoma tissue and cell lines.
J. Comp. Pathol. 148:178-187(2013)

PubMed=23410087; DOI=10.1111/vco.12019
Heather M. Wilson-Robles, Maria Daly, Catherine Pfent, Sabine Sheppard-Olivares;
Identification and evaluation of putative tumour-initiating cells in canine malignant melanoma cell lines.
Vet. Comp. Oncol. 13:60-69(2015)